Second Quarter Revenue of $307.7M Exceeds Prior GuidanceDelivers Sequential Expansion in Gross Profit and Adj. EBITDA MarginsAdvances Debt Reduction and […]
WORCESTER, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on […]